NG2 and DLL3 CAR-T Cells Targeting Melanoma
Clinical trial NCT07193966 · RECRUITING
Trial details
- NCT number
- NCT07193966
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.